The Golden Jubilee University National Hospital is a hospital in Clydebank, near Glasgow, Scotland. It was opened in 1994 and is managed by a Special Health Board appointed by NHS Scotland.

There are 163 beds in Golden Jubilee National Hospital.

During the past decade, Golden Jubilee National Hospital conducted 91 clinical trials. In the 10-year time frame, 91 clinical trials started and 20 clinical trials were completed, i.e. on average, 22% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 16 clinical trials were completed. i.e. 43.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Golden Jubilee National Hospital" #1 sponsor was "Golden Jubilee National Hospital" with 21 trials, followed by "Boston Scientific Corporation" with 10 trials sponsored, "NHS National Waiting Times Centre Board" with 9 trials sponsored, "Actelion" with 6 trials sponsored and "University of Glasgow" with 6 trials sponsored. Other sponsors include 70 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Golden Jubilee National Hospital" #1 collaborator was "British Heart Foundation" with 11 trials as a collaborator, "University of Glasgow" with 11 trials as a collaborator, "Golden Jubilee National Hospital" with 7 trials as a collaborator, "Abbott Medical Devices" with 5 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 4 trials as a collaborator. Other collaborators include 109 different institutions and companies that were collaborators in the rest 97 trials.

According to Clinical.Site data, the most researched conditions in "Golden Jubilee National Hospital" are "Coronary Artery Disease" (22 trials), "Heart Failure" (16 trials), "Pulmonary Arterial Hypertension" (12 trials), "Myocardial Infarction" (6 trials) and "PAH" (5 trials). Many other conditions were trialed in "Golden Jubilee National Hospital" in a lesser frequency.

Most popular intervention types in "Golden Jubilee National Hospital" are "Device" (54 trials), "Drug" (35 trials), "Other" (24 trials), "Procedure" (23 trials) and "Diagnostic Test" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ropivacaine" (3 trials), "Blood Sample" (2 trials), "Macitentan" (2 trials) and "Ralinepag" (2 trials). Other intervention names were less common.

The vast majority of trials in "Golden Jubilee National Hospital" are 127 trials for "All" genders.

Currently, there are 38 active trials in "Golden Jubilee National Hospital". 1 are not yet recruiting, 22 are recruiting, 11 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 57 completed trials in Golden Jubilee National Hospital, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Golden Jubilee National Hospital, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 62 trials that are defined as “Not Applicable".

Golden Jubilee National Hospital has several departments that took part in Clinical trials: "Scottish Pulmonary Vascular Unit" - 2 trials